Close Menu

NEW YORK (GenomeWeb News) – The shareholders of Vermillion have approved a 10 for one reverse stock split of the firm’s common shares.

The reverse split is scheduled to become effective at the close of business on March 3, the Fremont, Calif.-based firm said in a statement after the close of the market on Friday. Each ten shares of Vermillion common stock will be converted into one share under the plan, which will simultaneously increase the company’s stock price by a factor of 10.

Vermillion’s shares closed Friday at $.41 on the Nasdaq.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.

St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.

St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.

In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.